Explanation
Trastuzumab
Trastuzumab(Herceotin) isusedinthetreatmentofER2-receptor-positive metastatic breastcancer.
Trastuzumabisassociated withcardiomvopathyin between2%and7%of users.andtherskof
cardiomvopathyisincreasedwhenqiven incombination withanthracvcuine.
@1MINENDOCRINE
